Pangaea Oncology, S.A. announced a private placement of 2,500,000 shares at a par value of €0.02 per share and a €1.55 per share for a total gross proceeds of €3,875,000 on May 13, 2022. The transaction has been approved by the board of directors of the company and is subject to approval of the shareholders in a general meeting of June 13th.